Leptin-activated signaling and leptin-induced expression of target genes are inhibited by the nuclear Farnesoid X Receptor-(FXR), a tumor suppressor, through induction of the suppressor of the cytokine signaling 3 (SOCS3) [542]. The gene discussed is LEP; the disease is neoplasm.